Holen Sie sich die Stockscreener-App
36.35
1.03%
-0.08
Schlusskurs vom Vortag:
$36.43
Offen:
$36.59
24-Stunden-Volumen:
62,477
Relative Volume:
1.26
Marktkapitalisierung:
$440.11M
Einnahmen:
$9.71M
Nettoeinkommen (Verlust:
$-29.96M
KGV:
-10.45
EPS:
-3.48
Netto-Cashflow:
$-14.79M
1W Leistung:
-1.51%
1M Leistung:
-3.64%
6M Leistung:
+80.55%
1J Leistung:
+30.69%
1-Tages-Spanne:
$34.66
$37.00
1-Wochen-Bereich:
$34.66
$39.15
52-Wochen-Spanne:
$18.35
$39.92
Xoma Royalty Corp Stock (XOMA) Company Profile
Firmenname
Xoma Royalty Corp
Sektor
Branche
Telefon
510-204-7239
Adresse
2200 POWELL STREET, EMERYVILLE, CA
Vergleichen Sie XOMA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XOMA
Xoma Royalty Corp
|
36.41 | 440.36M | 9.71M | -29.96M | -14.79M | -3.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.60 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.79 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.54 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.70 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.41 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Xoma Royalty Corp Stock (XOMA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-17 | Eingeleitet | The Benchmark Company | Buy |
| 2024-04-29 | Eingeleitet | Leerink Partners | Outperform |
| 2021-09-07 | Herabstufung | Wedbush | Outperform → Neutral |
| 2021-06-29 | Eingeleitet | Aegis Capital | Buy |
| 2021-01-19 | Bestätigt | H.C. Wainwright | Buy |
| 2018-01-18 | Bestätigt | H.C. Wainwright | Buy |
| 2017-10-17 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-09-05 | Hochstufung | Wedbush | Neutral → Outperform |
| 2017-06-12 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-11-14 | Herabstufung | Wedbush | Outperform → Neutral |
| 2016-03-11 | Bestätigt | Wedbush | Outperform |
| 2015-07-23 | Herabstufung | Jefferies | Buy → Hold |
| 2015-07-22 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2015-07-22 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2014-10-10 | Fortgesetzt | ROTH Capital | Buy |
| 2014-04-29 | Hochstufung | MLV & Co | Hold → Buy |
| 2014-03-11 | Herabstufung | MLV & Co | Buy → Hold |
| 2014-03-05 | Bestätigt | Ladenburg Thalmann | Buy |
| 2013-10-31 | Bestätigt | MLV & Co | Buy |
| 2013-05-09 | Bestätigt | Ladenburg Thalmann | Buy |
| 2012-05-14 | Eingeleitet | Cowen & Co | Outperform |
| 2011-03-31 | Bestätigt | MLV Capital | Buy |
| 2011-03-23 | Bestätigt | RBC Capital Mkts | Outperform |
| 2011-01-06 | Bestätigt | Ladenburg Thalmann | Buy |
| 2011-01-04 | Bestätigt | Wedbush | Outperform |
Alle ansehen
Xoma Royalty Corp Aktie (XOMA) Neueste Nachrichten
Earnings visualization tools for XOMA Royalty Corporation2025 Trading Recap & Daily Profit Maximizing Tips - newser.com
Is XOMA Royalty Corporation stock bottoming outJuly 2025 Trade Ideas & Long-Term Growth Portfolio Plans - newser.com
What insider trading reveals about XOMA Royalty Corporation stockWeekly Volume Report & Verified Stock Trade Ideas - newser.com
Top chart patterns to watch in XOMA Royalty CorporationShort Setup & Daily Oversold Stock Bounce Ideas - newser.com
Short interest data insights for XOMA Royalty CorporationWeekly Trend Summary & Stock Portfolio Risk Management - newser.com
Is now a turning point for XOMA Royalty CorporationWeekly Gains Report & Capital Efficiency Focused Strategies - newser.com
Weiss Ratings Reiterates "Sell (D-)" Rating for XOMA Royalty (NASDAQ:XOMA) - MarketBeat
XOMA Co. (NASDAQ:XOMAO) Short Interest Up 66.7% in September - Defense World
XOMA Royalty (NASDAQ:XOMA) Stock Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Strategies to average down on XOMA Royalty CorporationMarket Performance Report & Fast Moving Stock Watchlists - newser.com
Why XOMA Royalty Corporation (X0M1) stock attracts HNW investorsJuly 2025 Technicals & Entry Point Strategy Guides - newser.com
XOMA Royalty PFD Update: Going Back To My Original Sell Ratings (NASDAQ:XOMA) - Seeking Alpha
XOMA Royalty Corporation (NASDAQ:XOMA) On The Verge Of Breaking Even - simplywall.st
Is XOMA Royalty Corporation stock poised for growth2025 Trading Volume Trends & Fast Moving Market Watchlists - newser.com
Will XOMA Royalty Corporation(X0M) stock outperform value peersTrend Reversal & Expert Verified Stock Movement Alerts - newser.com
Will XOMA Royalty Corporation (X0M1) stock profit from automation waveJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - newser.com
XOMA Royalty extends tender offer deadline for LAVA Therapeutics By Investing.com - Investing.com South Africa
XOMA Royalty extends tender offer deadline for LAVA Therapeutics - Investing.com
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V. - The Manila Times
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V. - Benzinga
75% CVR: XOMA Royalty Extends Tender Offer for LAVA, Extended to Oct. 17 - Stock Titan
Press Release: ESSA Pharma Inc. Amends Agreement With XenoTherapeutics - 富途牛牛
Press Release: XOMA Royalty Declares Quarterly Preferred Stock Dividends - 富途牛牛
Xoma announces closing of tender offer for HilleVax - MSN
What analysts say about XOMA Royalty CorporationX0M stockEx-Dividend Date Alerts & Analyze Your Portfolio Risk in Seconds - earlytimes.in
LAVA Therapeutics to Move Extraordinary General Meeting to Early November 2025 - Yahoo Finance
Is XOMA Royalty Corporation still worth holding after the dipJuly 2025 Analyst Calls & High Accuracy Trade Alerts - newser.com
Will XOMA Royalty Corporation (X0M1) stock hit analyst forecastsMarket Risk Summary & Entry Point Confirmation Alerts - newser.com
What makes XOMA Royalty Corporation stock attractive to growth fundsQuarterly Profit Summary & Long-Term Safe Investment Ideas - newser.com
Analyzing XOMA Royalty Corporation with multi timeframe charts2025 Institutional Moves & Fast Moving Market Watchlists - newser.com
Published on: 2025-09-29 02:44:30 - newser.com
XOMA Royalty Corporation stock momentum explained2025 Sector Review & Safe Capital Preservation Plans - newser.com
XOMA Royalty files correction to Series B preferred stock designation By Investing.com - Investing.com Nigeria
XOMA Royalty files correction to Series B preferred stock designation - Investing.com India
Why XOMA Royalty Corporation (X0M1) stock stays on buy listsJuly 2025 EndofMonth & Free Growth Oriented Trading Recommendations - newser.com
XOMA Royalty Declares Quarterly Preferred Stock Dividends - MSN
Essa Pharma Agrees to Amend Terms to Be Acquired by XenoTherapeutics - 富途牛牛
Xoma CFO Burns sells $155,820 in shares after option exercise By Investing.com - Investing.com South Africa
XOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment Conference - 富途牛牛
ESSA Pharma Inc. Amends Agreement with XenoTherapeutics24.09.25News - Ariva
Finanzdaten der Xoma Royalty Corp-Aktie (XOMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Xoma Royalty Corp-Aktie (XOMA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Hughes Owen | Chief Executive Officer |
Sep 19 '25 |
Option Exercise |
0.00 |
35,567 |
0 |
98,268 |
| BURNS THOMAS M. | SVP, Finance & CFO |
Sep 19 '25 |
Option Exercise |
0.00 |
11,846 |
0 |
34,409 |
| BURNS THOMAS M. | SVP, Finance & CFO |
Sep 22 '25 |
Sale |
35.99 |
4,330 |
155,820 |
30,079 |
| Montano Maricel Perea | Chief Legal Officer |
Sep 19 '25 |
Option Exercise |
0.00 |
3,033 |
0 |
12,134 |
| Montano Maricel Perea | Chief Legal Officer |
Sep 10 '25 |
Option Exercise |
0.00 |
9,101 |
0 |
9,101 |
| Sitko Bradley | Chief Investment Officer |
Jun 30 '25 |
Buy |
25.39 |
2,000 |
50,780 |
7,045 |
| Hughes Owen | Chief Executive Officer |
May 19 '25 |
Option Exercise |
0.00 |
53,359 |
0 |
88,338 |
| Hughes Owen | Chief Executive Officer |
May 20 '25 |
Sale |
25.38 |
25,637 |
650,667 |
62,701 |
| BURNS THOMAS M. | SVP, Finance & CFO |
May 19 '25 |
Option Exercise |
0.00 |
17,773 |
0 |
33,045 |
| BURNS THOMAS M. | SVP, Finance & CFO |
May 20 '25 |
Sale |
25.38 |
10,482 |
266,033 |
22,563 |
1.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):